Target
D(2) dopamine receptor
Ligand
BDBM141313
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
37±n/a nM
Citation
 Brown, DDamewood, JREdwards, PHulsizer, JMuir, JCPierson, Jr., MEShenvi, ABWesolowski, SWidzowski, DWood, M Dibenzothiazepine derivatives and uses thereof—424 US Patent  US8653257 Publication Date 2/18/2014 
Target
Name:
D(2) dopamine receptor
Synonyms:
D(2) dopamine receptor | DOPAMINE D2 | DOPAMINE D2 Long | DOPAMINE D2 Short | DRD2 | DRD2_HUMAN | Dopamine D2 receptor | Dopamine D2 receptor (D2) | Dopamine D2 receptor (D2R) | Dopamine D2A | Dopamine2-like | d2
Type:
Cell-surface receptors
Mol. Mass.:
50647.10
Organism:
Homo sapiens (Human)
Description:
P14416
Residue:
443
Sequence:
MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
  
Inhibitor
Name:
BDBM141313
Synonyms:
US8653257, 11-Piperazin-1-yl-dibenzo[b,f][1,4]thiazepine
Type:
Small organic molecule
Emp. Form.:
C17H17N3S
Mol. Mass.:
295.402
SMILES:
C1CN(CCN1)C1=Nc2ccccc2Sc2ccccc12 |t:7|
Structure:
Search PDB for entries with ligand similarity: